Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043992017> ?p ?o ?g. }
- W3043992017 endingPage "L512" @default.
- W3043992017 startingPage "L497" @default.
- W3043992017 abstract "Hyperoxia (HO)-induced lung injury contributes to bronchopulmonary dysplasia (BPD) in preterm newborns. Intractable wheezing seen in BPD survivors is associated with airway remodeling (AWRM). Sphingosine kinase 1 (SPHK1)/sphingosine-1-phosphate (S1P) signaling promotes HO-mediated neonatal BPD; however, its role in the sequela of AWRM is not known. We noted an increased concentration of S1P in tracheal aspirates of neonatal infants with severe BPD, and earlier, demonstrated that Sphk1 −/− mice showed protection against HO-induced BPD. The role of SPHK1/S1P in promoting AWRM following exposure of neonates to HO was investigated in a murine model. Therapy using PF543, the specific SPHK1 inhibitor, during neonatal HO reduced alveolar simplification followed by reduced AWRM in adult mice. This was associated with reduced airway hyperreactivity to intravenous methacholine. Neonatal HO exposure was associated with increased expression of SPHK1 in lung tissue of adult mice, which was reduced with PF543 therapy in the neonatal stage. This was accompanied by amelioration of HO-induced reduction of E-cadherin in airway epithelium. This may be suggestive of arrested partial epithelial mesenchymal transition (EMT) induced by HO. In vitro studies using human primary airway epithelial cells (HAEpCs) showed that SPHK1 inhibition or deletion restored HO-induced reduction in E-cadherin and reduced formation of mitochondrial reactive oxygen species (mtROS). Blocking mtROS with MitoTempo attenuated HO-induced partial EMT of HAEpCs. These results collectively support a therapeutic role for PF543 in preventing HO-induced BPD in neonates and the long-term sequela of AWRM, thus conferring a long-term protection resulting in improved lung development and function." @default.
- W3043992017 created "2020-07-29" @default.
- W3043992017 creator A5031382479 @default.
- W3043992017 creator A5031387348 @default.
- W3043992017 creator A5035375282 @default.
- W3043992017 creator A5041386908 @default.
- W3043992017 creator A5053411327 @default.
- W3043992017 creator A5057762061 @default.
- W3043992017 creator A5064859470 @default.
- W3043992017 creator A5091093014 @default.
- W3043992017 date "2020-09-01" @default.
- W3043992017 modified "2023-10-12" @default.
- W3043992017 title "Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia" @default.
- W3043992017 cites W1524650585 @default.
- W3043992017 cites W1560505485 @default.
- W3043992017 cites W1593263096 @default.
- W3043992017 cites W1857797615 @default.
- W3043992017 cites W1966608706 @default.
- W3043992017 cites W1981119944 @default.
- W3043992017 cites W1988033185 @default.
- W3043992017 cites W1994122881 @default.
- W3043992017 cites W1994281122 @default.
- W3043992017 cites W2001063978 @default.
- W3043992017 cites W2004313280 @default.
- W3043992017 cites W2012447265 @default.
- W3043992017 cites W2012519498 @default.
- W3043992017 cites W2015202977 @default.
- W3043992017 cites W2020170334 @default.
- W3043992017 cites W2023937509 @default.
- W3043992017 cites W2024902320 @default.
- W3043992017 cites W2030999139 @default.
- W3043992017 cites W2054921637 @default.
- W3043992017 cites W2055517121 @default.
- W3043992017 cites W2066121822 @default.
- W3043992017 cites W2069453014 @default.
- W3043992017 cites W2074467897 @default.
- W3043992017 cites W2101171129 @default.
- W3043992017 cites W2102806222 @default.
- W3043992017 cites W2105784843 @default.
- W3043992017 cites W2111464046 @default.
- W3043992017 cites W2117559606 @default.
- W3043992017 cites W2125524526 @default.
- W3043992017 cites W2134299879 @default.
- W3043992017 cites W2135570731 @default.
- W3043992017 cites W2140053474 @default.
- W3043992017 cites W2142641037 @default.
- W3043992017 cites W2146916955 @default.
- W3043992017 cites W2153640968 @default.
- W3043992017 cites W2157013848 @default.
- W3043992017 cites W2157852793 @default.
- W3043992017 cites W2186908796 @default.
- W3043992017 cites W2322652598 @default.
- W3043992017 cites W2345115057 @default.
- W3043992017 cites W2345918979 @default.
- W3043992017 cites W2402307408 @default.
- W3043992017 cites W2471950501 @default.
- W3043992017 cites W2504247086 @default.
- W3043992017 cites W2509232842 @default.
- W3043992017 cites W2530722683 @default.
- W3043992017 cites W2540431787 @default.
- W3043992017 cites W2564343953 @default.
- W3043992017 cites W2590090896 @default.
- W3043992017 cites W2608855402 @default.
- W3043992017 cites W2615010141 @default.
- W3043992017 cites W2728149853 @default.
- W3043992017 cites W2779265864 @default.
- W3043992017 cites W2802445320 @default.
- W3043992017 cites W2895024648 @default.
- W3043992017 cites W2895337076 @default.
- W3043992017 cites W2920937108 @default.
- W3043992017 cites W2946944153 @default.
- W3043992017 cites W2989356758 @default.
- W3043992017 cites W2994641002 @default.
- W3043992017 cites W2994965141 @default.
- W3043992017 cites W3012006264 @default.
- W3043992017 cites W33013484 @default.
- W3043992017 cites W4248251600 @default.
- W3043992017 doi "https://doi.org/10.1152/ajplung.00169.2020" @default.
- W3043992017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7518054" @default.
- W3043992017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32697651" @default.
- W3043992017 hasPublicationYear "2020" @default.
- W3043992017 type Work @default.
- W3043992017 sameAs 3043992017 @default.
- W3043992017 citedByCount "17" @default.
- W3043992017 countsByYear W30439920172020 @default.
- W3043992017 countsByYear W30439920172021 @default.
- W3043992017 countsByYear W30439920172022 @default.
- W3043992017 countsByYear W30439920172023 @default.
- W3043992017 crossrefType "journal-article" @default.
- W3043992017 hasAuthorship W3043992017A5031382479 @default.
- W3043992017 hasAuthorship W3043992017A5031387348 @default.
- W3043992017 hasAuthorship W3043992017A5035375282 @default.
- W3043992017 hasAuthorship W3043992017A5041386908 @default.
- W3043992017 hasAuthorship W3043992017A5053411327 @default.
- W3043992017 hasAuthorship W3043992017A5057762061 @default.
- W3043992017 hasAuthorship W3043992017A5064859470 @default.
- W3043992017 hasAuthorship W3043992017A5091093014 @default.
- W3043992017 hasBestOaLocation W30439920171 @default.